Molecular Basis for Vaccine Development against the Ehrlichial Pathogen Anaplasma marginale
- 1 July 1999
- journal article
- review article
- Published by Elsevier in Parasitology Today
- Vol. 15 (7) , 281-286
- https://doi.org/10.1016/s0169-4758(99)01469-6
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Immunity to Asexual Blood Stages of Plasmodium: Is Resistance to Acute Malaria Adaptive or Innate?Parasitology Today, 1998
- Anaplasma marginale: effect of the treatment of cattle with an interferon γ‐neutralizing monoclonal antibody or the nitric oxide synthetase inhibitor aminoguanidine on the course of infectionParasite Immunology, 1997
- Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle.Proceedings of the National Academy of Sciences, 1996
- Emergence of the Ehrlichioses as Human Health ProblemsEmerging Infectious Diseases, 1996
- Molecular basis for vaccine development against anaplasmosis and babesiosisVeterinary Parasitology, 1995
- Heterologous strain challenge of cattle immunized with Anaplasma marginale outer membranesVeterinary Immunology and Immunopathology, 1994
- IFN-γ Stimulates IgG2 Production from Bovine B Cells Costimulated with Anti-μ and MitogenCellular Immunology, 1994
- Opsonization of Anaplasma marginale mediated by bovine antibody against surface protein MSP-1Veterinary Immunology and Immunopathology, 1993
- Molecular basis for surface antigen size polymorphisms and conservation of a neutralization-sensitive epitope in Anaplasma marginale.Proceedings of the National Academy of Sciences, 1990
- Cell-mediated immunity in bovine anaplasmosis and correlation with protection induced by vaccination (a review)Veterinary Parasitology, 1976